Example of ACS Infectious Diseases format
Recent searches

Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format Example of ACS Infectious Diseases format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

ACS Infectious Diseases — Template for authors

Categories Rank Trend in last 3 yrs
Infectious Diseases #63 of 288 up up by 25 ranks
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 764 Published Papers | 4620 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 26/06/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access
recommended Recommended

PLOS

Quality:  
High
CiteRatio: 7.1
SJR: 1.99
SNIP: 1.774
open access Open Access
recommended Recommended

Oxford University Press

Quality:  
High
CiteRatio: 9.1
SJR: 2.124
SNIP: 1.646
open access Open Access

Frontiers Media

Quality:  
High
CiteRatio: 6.5
SJR: 1.812
SNIP: 1.485
open access Open Access
recommended Recommended

American Society for Microbiology

Quality:  
High
CiteRatio: 9.1
SJR: 2.07
SNIP: 1.44

Journal Performance & Insights

CiteRatio

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

A measure of average citations received per peer-reviewed paper published in the journal.

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

6.0

18% from 2019

CiteRatio for ACS Infectious Diseases from 2016 - 2020
Year Value
2020 6.0
2019 7.3
2018 6.0
2017 4.3
2016 2.2
graph view Graph view
table view Table view

1.324

18% from 2019

SJR for ACS Infectious Diseases from 2016 - 2020
Year Value
2020 1.324
2019 1.614
2018 1.759
2017 1.618
2016 1.152
graph view Graph view
table view Table view

1.029

17% from 2019

SNIP for ACS Infectious Diseases from 2016 - 2020
Year Value
2020 1.029
2019 1.242
2018 1.171
2017 1.061
2016 0.889
graph view Graph view
table view Table view

insights Insights

  • CiteRatio of this journal has decreased by 18% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

insights Insights

  • SJR of this journal has decreased by 18% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has decreased by 17% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

ACS Infectious Diseases

Guideline source: View

Potential, possible, or probable predatory scholarly open-access publishers.

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

American Chemical Society

ACS Infectious Diseases

ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to: Discovery and development of new antimicrobial agent...... Read More

Infectious Diseases

Medicine

i
Last updated on
26 Jun 2020
i
ISSN
2373-8227
i
Open Access
No
i
Sherpa RoMEO Archiving Policy
White faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Bibliography Name
ACS Custom Citation (achemso)
i
Citation Type
Numbered (Superscripted)
25
i
Bibliography Example
Beenakker, C. W. J. Specular Andreev Reflection in Graphene. Phys. Rev. Lett. 2006, 97, 067007.

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.1021/ACSINFECDIS.5B00097
Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It
Helen I. Zgurskaya1, Cesar A. Lopez2, Sandrasegaram Gnanakaran2
25 Sep 2015 - ACS Infectious Diseases

Abstract:

Gram-negative bacteria are intrinsically resistant to many antibiotics. Species that have acquired multidrug resistance and cause infections that are effectively untreatable present a serious threat to public health. The problem is broadly recognized and tackled at both the fundamental and applied levels. This paper summarize... Gram-negative bacteria are intrinsically resistant to many antibiotics. Species that have acquired multidrug resistance and cause infections that are effectively untreatable present a serious threat to public health. The problem is broadly recognized and tackled at both the fundamental and applied levels. This paper summarizes current advances in understanding the molecular bases of the low permeability barrier of Gram-negative pathogens, which is the major obstacle in discovery and development of antibiotics effective against such pathogens. Gaps in knowledge and specific strategies to break this barrier and to achieve potent activities against difficult Gram-negative bacteria are also discussed. read more read less
View PDF
394 Citations
Journal Article DOI: 10.1021/ACSINFECDIS.5B00047
Quaternary Ammonium Compounds: An Antimicrobial Mainstay and Platform for Innovation to Address Bacterial Resistance
Megan C. Jennings1, Kevin P. C. Minbiole2, William M. Wuest1
29 May 2015 - ACS Infectious Diseases

Abstract:

Quaternary ammonium compounds (QACs) have represented one of the most visible and effective classes of disinfectants for nearly a century. With simple preparation, wide structural variety, and versatile incorporation into consumer products, there have been manifold developments and applications of these structures. Generally ... Quaternary ammonium compounds (QACs) have represented one of the most visible and effective classes of disinfectants for nearly a century. With simple preparation, wide structural variety, and versatile incorporation into consumer products, there have been manifold developments and applications of these structures. Generally operating via disruption of one of the most fundamental structures in bacteria-the cell membrane-leading to cell lysis and bacterial death, the QACs were once thought to be impervious to resistance. Developments over the past decades, however, have shown this to be far from the truth. It is now known that a large family of bacterial genes (generally termed qac genes) encode efflux pumps capable of expelling many QAC structures from bacterial cells, leading to a decrease in susceptibility to QACs; methods of regulation of qac transcription are also understood. Importantly, qac genes can be horizontally transferred via plasmids to other bacteria and are often transmitted alongside other antibiotic-resistant genes; this dual threat represents a significant danger to human health. In this review, both QAC development and QAC resistance are documented, and possible strategies for addressing and overcoming QAC-resistant bacteria are discussed. read more read less
391 Citations
open accessOpen access Journal Article DOI: 10.1021/ACSINFECDIS.6B00041
Therapeutic Potential of Spirooxindoles as Antiviral Agents.
Na Ye1, Haiying Chen1, Eric A. Wold1, Pei Yong Shi1, Jia Zhou1
05 May 2016 - ACS Infectious Diseases

Abstract:

Antiviral therapeutics with profiles of high potency, low resistance, panserotype, and low toxicity remain challenging, and obtaining such agents continues to be an active area of therapeutic development. Due to their unique three-dimensional structural features, spirooxindoles have been identified as privileged chemotypes fo... Antiviral therapeutics with profiles of high potency, low resistance, panserotype, and low toxicity remain challenging, and obtaining such agents continues to be an active area of therapeutic development. Due to their unique three-dimensional structural features, spirooxindoles have been identified as privileged chemotypes for antiviral drug development. Among them, spiro-pyrazolopyridone oxindoles have been recently reported as potent inhibitors of dengue virus NS4B, leading to the discovery of an orally bioavailable preclinical candidate (R)-44 with excellent in vivo efficacy in a dengue viremia mouse model. This review highlights recent advances in the development of biologically active spirooxindoles for their antiviral potential, primarily focusing on the structure–activity relationships (SARs) and modes of action, as well as future directions to achieve more potent analogues toward a viable antiviral therapy. read more read less

Topics:

Antiviral drug (53%)53% related to the paper
303 Citations
open accessOpen access Journal Article DOI: 10.1021/ACSINFECDIS.6B00006
Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates
11 Apr 2016 - ACS Infectious Diseases

Abstract:

Severe acute respiratory syndrome (SARS) is caused by a coronavirus (SARS-CoV) and has the potential to threaten global public health and socioeconomic stability. Evidence of antibody-dependent enhancement (ADE) of SARS-CoV infection in vitro and in non-human primates clouds the prospects for a safe vaccine. Using antibodies ... Severe acute respiratory syndrome (SARS) is caused by a coronavirus (SARS-CoV) and has the potential to threaten global public health and socioeconomic stability. Evidence of antibody-dependent enhancement (ADE) of SARS-CoV infection in vitro and in non-human primates clouds the prospects for a safe vaccine. Using antibodies from SARS patients, we identified and characterized SARS-CoV B-cell peptide epitopes with disparate functions. In rhesus macaques, the spike glycoprotein peptides S471–503, S604–625, and S1164–1191 elicited antibodies that efficiently prevented infection in non-human primates. In contrast, peptide S597–603 induced antibodies that enhanced infection both in vitro and in non-human primates by using an epitope sequence-dependent (ESD) mechanism. This peptide exhibited a high level of serological reactivity (64%), which resulted from the additive responses of two tandem epitopes (S597–603 and S604–625) and a long-term human B-cell memory response with antisera from convalescent SARS patie... read more read less

Topics:

Coronavirus (57%)57% related to the paper, Epitope (56%)56% related to the paper
View PDF
269 Citations
open accessOpen access Journal Article DOI: 10.1021/ACSINFECDIS.0C00052
Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential.
Jimin Xu, Pei Yong Shi, Hongmin Li1, Jia Zhou
10 Mar 2020 - ACS Infectious Diseases

Abstract:

The recent outbreak of coronavirus disease 2019 (COVID-19) highlights an urgent need for therapeutics. Through a series of drug repurposing screening campaigns, niclosamide, an FDA-approved anthelminthic drug, was found to be effective against various viral infections with nanomolar to micromolar potency such as SARS-CoV, MER... The recent outbreak of coronavirus disease 2019 (COVID-19) highlights an urgent need for therapeutics. Through a series of drug repurposing screening campaigns, niclosamide, an FDA-approved anthelminthic drug, was found to be effective against various viral infections with nanomolar to micromolar potency such as SARS-CoV, MERS-CoV, ZIKV, HCV, and human adenovirus, indicating its potential as an antiviral agent. In this brief review, we summarize the broad antiviral activity of niclosamide and highlight its potential clinical use in the treatment of COVID-19. read more read less

Topics:

Niclosamide (56%)56% related to the paper
239 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for ACS Infectious Diseases.

It automatically formats your research paper to American Chemical Society formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

ACS Infectious Diseases format uses ACS Custom Citation (achemso) citation style.

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write ACS Infectious Diseases in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the ACS Infectious Diseases guidelines and auto format it.

2. Do you follow the ACS Infectious Diseases guidelines?

Yes, the template is compliant with the ACS Infectious Diseases guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in ACS Infectious Diseases?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the ACS Infectious Diseases citation style.

4. Can I use the ACS Infectious Diseases templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for ACS Infectious Diseases.

5. Can I use a manuscript in ACS Infectious Diseases that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper ACS Infectious Diseases that you can download at the end.

6. How long does it usually take you to format my papers in ACS Infectious Diseases?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in ACS Infectious Diseases.

7. Where can I find the template for the ACS Infectious Diseases?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per ACS Infectious Diseases's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the ACS Infectious Diseases's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. ACS Infectious Diseases an online tool or is there a desktop version?

SciSpace's ACS Infectious Diseases is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like ACS Infectious Diseases?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like ACS Infectious Diseases?”

11. What is the output that I would get after using ACS Infectious Diseases?

After writing your paper autoformatting in ACS Infectious Diseases, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is ACS Infectious Diseases's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for ACS Infectious Diseases?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for ACS Infectious Diseases. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In ACS Infectious Diseases?

The 5 most common citation types in order of usage for ACS Infectious Diseases are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the ACS Infectious Diseases?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per ACS Infectious Diseases's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download ACS Infectious Diseases in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in ACS Infectious Diseases Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to ACS Infectious Diseases formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template